ALNY: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/f274d10a-c50f-40ca-a92e-44944bb8fb28/","filing_uuid":"f274d10a-c50f-40ca-a92e-44944bb8fb28","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/f274d10a-c50f-40ca-a92e-44944bb8fb28/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jonathan Jones, Partner","dt_posted":"2026-10-19T17:43:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"750 9th Street NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":20744,"url":"https://lda.gov/api/v1/registrants/20744/","house_registrant_id":31587,"name":"TIBER CREEK GROUP","description":"Government Relations.","address_1":"750 9th Street NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GRACE BAUM","contact_telephone":"+1 202-381-6896","dt_updated":"2026-07-20T13:07:00.819992-04:00"},"client":{"id":54640,"url":"https://lda.gov/api/v1/clients/54640/","client_id":54640,"name":"ALNYLAM PHARMACEUTICALS, INC.","general_description":"Biopharmaceuticals.","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-01-26"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47178,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"MICHAEL","last_name":"GONZALEZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107185,"prefix":null,"prefix_display":null,"first_name":"COREY","nickname":null,"middle_name":null,"last_name":"MALMGREN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26450,"prefix":null,"prefix_display":null,"first_name":"JONATHON","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107259,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"KIRKLAND","last_name":"TWOMEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}